HSBC Holdings
DXCM icon

HSBC Holdings’s DexCom DXCM Stock Holding History

HSBC Holdings’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.5M Sell
1,090,200
-38,600
-3% -$2.57M 0.03% 450
2026
Q1 		$71.3M Sell
1,128,800
-145,600
-11% -$10.1M 0.04% 415
2025
Q4 		$84.9M Buy
1,274,400
+487,900
+62% +$31.5M 0.04% 363
2025
Q3 		$52.6M Buy
786,500
+139,900
+22% +$11.1M 0.03% 475
2025
Q2 		$56.2M Sell
646,600
-11,800
-2% -$925K 0.03% 453
2025
Q1 		$44.5M Buy
658,400
+256,000
+64% +$20.9M 0.03% 507
2024
Q4 		$31.4M Buy
402,400
+132,600
+49% +$9.82M 0.02% 609
2024
Q3 		$18.1M Buy
269,800
+165,300
+158% +$13.6M 0.01% 756
2024
Q2 		$11.9M Buy
104,500
+40,500
+63% +$5.12M 0.01% 828
2024
Q1 		$8.88M Sell
64,000
-24,900
-28% -$3.13M 0.01% 924
2023
Q4 		$11.1M Sell
88,900
-41,000
-32% -$4.19M 0.01% 861
2023
Q3 		$12.3M Buy
129,900
+72,800
+127% +$8.21M 0.01% 767
2023
Q2 		$7.32M Buy
57,100
+3,700
+7% +$448K 0.01% 918
2023
Q1 		$6.11M Buy
53,400
+2,700
+5% +$302K 0.01% 1030
2022
Q4 		$5.7M Buy
50,700
+20,900
+70% +$2.29M 0.01% 1194
2022
Q3 		$2.42M Buy
29,800
+9,800
+49% +$830K ﹤0.01% 1482
2022
Q2 		$1.5M Buy
20,000
+12,400
+163% +$1.13M ﹤0.01% 1725
2022
Q1 		$972K Hold
7,600
– – ﹤0.01% 1962
2021
Q4 		$1.02M Hold
7,600
– – ﹤0.01% 2035
2021
Q3 		$1.04M Buy
7,600
+800
+12% +$101K ﹤0.01% 1859
2021
Q2 		$726K Buy
6,800
+2,800
+70% +$269K ﹤0.01% 1941
2021
Q1 		$359K Hold
4,000
– – ﹤0.01% 2192
2020
Q4 		$370K Hold
4,000
– – ﹤0.01% 2420
2020
Q3 		$412K Hold
4,000
– – ﹤0.01% 2061
2020
Q2 		$405K Buy
+4,000
New +$358K ﹤0.01% 1964
2019
Q3 		– Sell
-5,600
Closed -$210K – 3081
2019
Q2 		$210K Hold
5,600
– – ﹤0.01% 2530
2019
Q1 		$167K Buy
+5,600
New +$197K ﹤0.01% 2589

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HSBC Holdings's DXCM Position: Q2 2026 in Review

HSBC Holdings increased its DexCom (DXCM) stake by 3.6% in Q2 2026, buying an estimated $2.82M and bringing the position to 1,208,920 shares worth $81.9M. The position accounts for 0.03% of the portfolio, ranked #433.

HSBC Holdings first reported a position in DXCM in Q1 2015 and has held it in 46 quarters since. The position peaked at $143M in Q2 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • HSBC Holdings held 1,208,920 shares of DexCom worth $81.9M as of Q2 2026.
  • HSBC Holdings bought 42,377 DexCom shares in Q2 2026, an estimated $2.82M.
  • DexCom made up 0.03% of HSBC Holdings's portfolio in Q2 2026, its #433 holding.
  • HSBC Holdings first reported a position in DexCom in Q1 2015 and has held it in 46 quarters since.
  • HSBC Holdings's DexCom position peaked at $143M in Q2 2024.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.